|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02186 LUYE PHARMA
Nominal 
2.710 +0.200 (+7.968%) Non-current Assets
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Investment Properties | -- | -- | 0 | 0 | 0 | 0 |
| Property, plant, equip. & others | -- | -- | 5,004,624 | 4,751,937 | 4,255,990 | 3,858,491 |
| Land & other Lease Assets | -- | -- | 334,581 | 336,568 | 333,307 | 344,990 |
| Intangible Assets | -- | -- | 7,597,943 | 7,359,810 | 6,988,055 | 6,427,246 |
| Interests in Asso. & JCEs | -- | -- | 1,871,107 | 1,388,197 | 7,781 | 8,659 |
| Other Non-current Assets | -- | -- | 1,495,838 | 950,921 | 1,878,679 | 1,546,011 |
| -- | -- | 16,304,093 | 14,787,433 | 13,463,812 | 12,185,397 | |
Current Assets
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Inventories | -- | -- | 911,893 | 827,863 | 772,939 | 746,344 | |
| Trade Receivables | -- | -- | 2,779,767 | 2,359,073 | 1,783,686 | 1,765,096 | |
| Cash & Bank Balances | -- | -- | 4,937,145 | 3,238,973 | 2,323,740 | 2,438,252 | |
| Other Current Assets | -- | -- | 4,679,302 | 4,277,373 | 5,905,448 | 5,446,972 | |
| Assets Held for Sale | -- | -- | 0 | 0 | 0 | 0 | |
| -- | -- | 13,308,107 | 10,703,282 | 10,785,813 | 10,396,664 | ||
Current Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |||
| Trade Payables | -- | -- | 689,300 | 767,187 | 559,944 | 570,890 | ||
| S-T Debt & Leases | -- | -- | 7,585,074 | 5,195,754 | 6,839,788 | 5,263,216 | ||
| Other Current Liabilities | -- | -- | 2,494,768 | 2,174,866 | 2,087,471 | 1,496,087 | ||
| Liab asso w/ Assets Held for Sale | -- | -- | 0 | 0 | 0 | 0 | ||
| -- | -- | 10,769,142 | 8,137,807 | 9,487,203 | 7,330,193 | |||
| Net Current Assets | -- | -- | 2,538,965 | 2,565,475 | 1,298,610 | 3,066,471 | ||
| Total Assets Less Current Liabilities | -- | -- | 18,843,058 | 17,352,908 | 14,762,422 | 15,251,868 | ||
Non-current Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||||
| L-T Debt & Leases | -- | -- | 2,735,980 | 3,228,193 | 2,264,731 | 4,227,577 | |||
| Other Non-current Liabilities | -- | -- | 353,408 | 596,221 | 1,455,969 | 1,910,388 | |||
| -- | -- | 3,089,388 | 3,824,414 | 3,720,700 | 6,137,965 | ||||
Capital and Reserves
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |||||
| Share Capital | -- | -- | 486,107 | 486,107 | 456,953 | 455,835 | ||||
| Reserves | -- | -- | 13,207,063 | 11,658,716 | 9,719,001 | 7,739,890 | ||||
| Others | -- | -- | 461,359 | 386,362 | 0 | 292,398 | ||||
| Shareholders' Funds | -- | -- | 14,154,529 | 12,531,185 | 10,175,954 | 8,488,123 | ||||
| Non-controlling Interests | -- | -- | 1,599,141 | 997,309 | 865,768 | 625,780 | ||||
| Others | -- | -- | 0 | 0 | 0 | 0 | ||||
| -- | -- | 15,753,670 | 13,528,494 | 11,041,722 | 9,113,903 | |||||
Commitments and Contingent Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Commitments | -- | -- | 469,593 | 903,674 | 966,886 | 977,221 |
| Contingent Liabilities | -- | -- | 0 | 0 | 0 | 0 |
| Remarks: | Real time quote last updated: 01/04/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 618,747 |
| %Change | 31.122% |
| EPS / (LPS) | RMB 0.159 |
| NBV Per Share (¥) | RMB -- |